A piperidine compound of the formula (I):
wherein A is a fused aromatic ring; R is hydrogen, chloro or methoxy; X is (CH2)n, which may be substituted, in which n is 0 or an integer of 1 to 10, --CH≡CH--, --C≡C--, --O--, --S--, --NH--, --N(COCH3)--, --N(COOC2H5)--, --N(CHO)--, --N(CH3)--, --CO--, --SO--, or --SO2--; Y is --CH≡CH--, --CH2CH2--, --CH2CO--, --O--, --S--, --NH--, --OCH2--, --SCH2--, --NHCH2--, --CH(OH)CH2-- or --CH(OH)CH(OH)--; and Q is substituted or unsubstituted n-hexyl, carboxypropyl, ethoxycarbonylpropyl, cyanopropyl, cyclohexyl, phenyl, indanyl, naphthyl, tetrahydronaphthyl, benzocycloheptyl, piperidinyl, tetrahydroisoquinolinyl, indolyl, pyrolyl, furyl, thienyl, thiazolyl, oxazolyl or N-methylpyrolyl, wherein any one or more of the --(CH2)-groups of the hexyl, carboxypropyl, ethoxycarbonylpropyl and cyanopropyl groups may be replaced by --CH≡CH--, --C≡C--, --O--, --S--, --NH--, --N(COCH3), --N(COC2H5)--, --N(CHO)--, --N(CH3), --CO--, --SO-- or --SO2--, and wherein one or more of the --(CH2)-groups in X and Q may be substituted by --(CH2)4-- or --(CH2)5-- thereby forming a ring structure.
12. A piperidine compound of the formula
wherein:
R is --H, --Cl or --OCH3; X is --(CH2)n--; n is an integer of from 3 to 5; and Q is --CN, substituted or unsubstituted phenyl, substituted or unsubstituted furyl, substituted or unsubstituted thienyl, substituted or unsubstituted pyrrolyl, substituted or unsubstituted pyridyl, wherein when Q is substituted, the substituent(s) is/are selected from the group consisting of HCH2n wherein n is an integer of 1 to 10, ClCH23, allyl, phenyl, isopropyl, hydroxy, methoxy, ethoxy, fluoro, chloro, acetoxy, 2-methoxyacetoxy, ethoxycarboxyl, carboxyl, methoxycarbonyl, ethoxycarbonyl, cyano, imidazolylmethyl, trifluoromethyl, benzoyl, 2-hydroxybenzyl, nitro, amino, acetylamino, propanoylamino, butanoylamino, pivaloylamino, trifluoromethylamino, methoxycarbonylamino, ethoxycarbonylamino, cinnamoylamino, methanesulfonylamino, N,N-bis(methanesulfonyl)amino, aminocarbonyl, aminosulfonyl, hydroxymethyl and acetoxymethyl, and wherein one or more of the CH2 groups in X may be substituted by CH24 or CH25 thereby forming a ring structure.
9. A piperidine compound of the formula
wherein:
R is --H, --Cl or --OCH3; X is --(CH2)n--, --CO--(CH2)3, --CONH--(CH2)2, --NHCO--(CH2)2, or --CH≡CH--(CH2)2--; and n is an integer of from 3 to 5; Y is --CH≡CH--, --(CH2)2--, --OCH2--, --SCH2--; and Q is --CN, substituted or unsubstituted piperidinyl, substituted or unsubstituted piperazinyl, substituted or unsubstituted thienyl, substituted or unsubstituted morpholinyl, or substituted or unsubstituted thiomorpholinyl, wherein when Q is substituted, the substituent(s) is/are selected from the group consisting of HCH2n wherein n is an integer of 1 to 10, ClCH23, allyl, formyl, phenyl, isopropyl, hydroxy, methoxy, ethoxy, fluoro, chloro, acetoxy, 2-methoxyacetoxy, carboxyl, methoxycarbonyl, ethoxycarbonyl, cyano, imidazolylmethyl, trifluoromethyl, benzoyl, 2-hdyroxybenzyl, nitro, amino, acetylamino, propanoylamino, butanoylamino, pivaloylamino, trifluoromethylamino, methoxycarbonylamino, ethoxycarbonylamino, cinnamoylamino, methanesulfonylamino, N,N-bis(methanesulfonyl)amino, aminocarbonyl, aminosulfonyl, hydroxymethyl and acetoxymethyl, and wherein when X and/or Q contain CH2groups, one or more of the CH2 groups in X and/or Q may be substituted by CH24 or CH25, thereby forming a ring structure.
11. A piperidine compound of the formula
wherein:
R is --H, --Cl or --OCH3; X is --CO--(CH2)3, --CONH--(CH2)2, --NHCO--(CH2)2, or --CH≡CH-- (CH2)2--; and Q is --CN, substituted or unsubstituted cyclohexyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted piperazinyl, substituted or unsubstituted phenyl, substituted or unsubstituted furyl, substituted or unsubstituted thienyl, substituted or unsubstituted pyrrolyl, substituted or unsubstituted pyridyl, substituted or unsubstituted morpholinyl, or substituted or unsubstituted thiomorpholinyl, wherein when Q is substituted, the substituent(s) is/are selected from the group consisting of HCH2n wherein n is an integer of 1 to 10, ClCH23, allyl, phenyl, isopropyl, hydroxy, methoxy, ethoxy, fluoro, chloro, acetoxy, 2-methoxyacetoxy, ethoxycarboxyl, carboxyl, methoxycarbonyl, ethoxycarbonyl, cyano, imidazolylmethyl, trifluoromethyl, benzoyl, 2-hydroxybenzyl, nitro, amino, acetylamino, propanoylamino, butanoylamino, pivaloylamino, trifluoromethylamino, methoxycarbonylamino, ethoxycarbonylamino, cinnamoylamino, methanesulfonylamino, N,N-bis(methanesulfonyl)amino, aminocarbonyl, aminosulfonyl, hydroxymethyl and acetoxymethyl, and wherein when X and/or Q contain CH2 groups, one or more of the CH2 groups in X and/or Q may be substituted by CH24 or CH25 thereby forming a ring structure.
1. A piperidine compound of the formula (I)
wherein:
A is pyridine; R is --H, --Cl or --OCH3; X is --(CH2)n--, --CO--(CH2)3, --CONH--(CH2)2, --NHCO--(CH2)2, or --CH≡CH--(CH2)2--; and n is an integer of from 3 to 5; Y is --CH≡CH--, --(CH2)2, --OCH2--, --SCH2--, or --O--; and Q is --CN, substituted or unsubstituted cyclohexyl, substituted or unsubstituted piperidinyl, substituted or unsubstituted piperazinyl, substituted or unsubstituted phenyl, substituted or unsubstituted furyl, substituted or unsubstituted thienyl, substituted or unsubstituted pyrrolyl, substituted or unsubstituted pyridyl, substituted or unsubstituted morpholinyl, or substituted or unsubstituted thiomorpholinyl, wherein when Q is substituted, the substituent(s) is/are selected from the group consisting of HCH2n wherein n is an integer of 1 to 10, ClCH23, allyl, phenyl, isopropyl, hydroxy, methoxy, ethoxy, fluoro, chloro, acetoxy, 2-methoxyacetoxy, ethoxycarboxyl, carboxyl, methoxycarbonyl, ethoxycarbonyl, cyano, imidazolylmethyl, trifluoromethyl, benzoyl, 2-hydroxybenzyl, nitro, amino, acetylamino, propanoylamino, butanoylamino, pivaloylamino, trifluoromethylamino, methoxycarbonylamino, ethoxycarbonylamino, cinnamoylamino, methanesulfonylamino, N,N-bis(methanesulfonyl)amino, aminocarbonyl, aminosulfonyl, hydroxymethyl and acetoxymethyl, and wherein when X and/or Q contain CH2 groups, one or more of the CH2 groups in X and/or Q may be substituted by CH24 CH25, thereby forming a ring structure.
2. The piperidine compound of
3. The piperidine compound of
8. The piperidine compound of
10. The piperidine compound of
0. 13. The piperidine compounds of
|
This application is a reissue application of application Ser. No. 08/269,628, filed Jul. 1, 1994, now U.S. Pat. No. 5,393,890 which in turn is a continuation of application Ser. No. 08/072,458, filed Jun. 7, 1993, now abandoned, which is a continuation of application Ser. No. 07/655,775, filed Feb. 15, 1991, now U.S. Pat. No. 5,250,681, which is a continuation of application Ser. No. 07/443,438, filed Nov. 30, 1989, now abandoned, which is a continuation of application Ser. No. 07/354,880, filed May 22, 1989, now U.S. Pat. No. 5,231,105, which is a continuation of application Ser. No. 07/201,911, filed Jun. 2, 1988, now abandoned.
The present invention relates to a piperidine derivative and hypotensives containing the same.
It is said that there are about 13,000,000 patients with hypertension in Japan and its frequency of occurrence in individuals becomes greater with advancing age. Further, as the age of a given population increases, increased attention is directed to hypertension which becomes more and more of a dangerous factor in severe heart and cerebral diseases represented by cardiac infarction and cerebral apoplexy. In recent years, calcium antagonists or angiotensin convertase inhibitors have been widely used as excellent primary selection drugs for treatment of hypertension. But the pharmaceutical effects or safety of these hypotensives have recently come into question.
A need therefore continues to exist for new hypotensive agents which exhibit excellent pharmaceutical effects and safety which can be industrially prepared at low cost and in a simple manner.
Accordingly, one object of the present invention is to provide an effective hypotensive agent which is relatively simple to prepare at low cost.
Briefly, this object and other objects of the present invention as hereinafter will become more readily apparent can be attained by a piperidine derivative of formula (I):
wherein A is a fused aromatic ring; R is hydrogen, chloro or methoxy; X is (CH2)n, which may be substituted, in which n is 0 or an integer of 1 to 10, --CH≡CH--, --C≡C--, --O--, --S--, --NH--, --N(COCH3)--, --N(COOC2H5)--, --N(CHO)--, --N(CH3)--, --CO--, --SO--, or --SO2--; Y is --CH≡CH--, --CH2CH2--, --CH2CO--, --O--, --S--, --NH--, --OCH2--, --SCH2--, --NHCH2--, --CH(OH)CH2--or --CH (OH) CH (OH) --; and Q is substituted or unsubstituted n-hexyl, carboxypropyl, ethoxycarbonylpropyl, cyanopropyl, cyclohexyl, phenyl, indanyl, naphthyl, tetrahydronaphthyl, benzocycloheptyl, piperidinyl, tetrahydroisoquinolinyl, indolyl, pyrolyl, furyl, thienyl, thiazolyl, oxazolyl or N-methylpyrolyl, wherein any one or more of the --(CH2)-groups of the hexyl, carboxypropyl, ethoxycarbonylpropyl and cyanopropyl groups may be replaced by --CH≡CH--, --C≡C--, --O--, --S--, --NH--, --N (COCH3), --N(COC2H5)--, --N(CHO)--, --N(CH3)--, --CO--, --SO-- or --SO2--, and wherein one or more of the --(CH2)-groups in X and Q may be substituted by --(CH2)4-- or --(CH2)5-- thereby forming a ring structure.
It has now been discovered that piperidine derivatives of the formula (I) above are effective as hypotensive agents. The present piperidine derivative exhibits excellent hypotensive action, its method of synthesis is simple and its derivatives can be easily prepared.
In formula (I), the fused aromatic ring (A) is a fused benzene, thiophene, pyridine or the like ring. Further, in formula (I) above, substituents X and Q may be substituted by at least one substituent selected from the group consisting of H(CH2)n, wherein n is 1 to 10, C1(CH2)3, allyl, phenyl, isopropyl, hydroxy, methoxy, ethoxy, fluoro, chloro, acetoxy, 2-methoxyacetoxy, ethoxycarboxy, carboxyl, methoxycarbonyl, ethoxycarbonyl, cyano, imidazolylmethyl, trifluoromethyl, benzoyl, 2-hydroxybenzyl, nitro, amino, acetylamino, propanoylamino, butanoylamino, pivaloylamino, trifluoromethylamino, methoxycarbonylamino, ethoxycarbonylamino, cinnamoylamino, methanesulfonylamino, N,N-bis(methanesulfonyl)amino, aminocarbonyl, aminosulfonyl, hydroxymethyl and acetoxymethyl.
The method of administration of the present piperidine derivative when used as a hypotensive, include oral and parenteral routes. Dose is determined depending upon age, body weight and condition of the patient and route of administration. Daily dose is generally 0.01 to 2000 mg/kg for oral administration. In the case of parenteral administration, the daily dose is 0.01 to 1000 mg/kg. The present piperidine derivative may be prepared in the form of ordinary preparations such as for example, tablets, powders, capsules, solutions, sugar--coated tablets or depots, which may be prepared in a conventional manner using conventional preparation aids. For example, tablets can be obtained by mixing the piperidine derivative of the present invention diluents (e.g., lactose, calcium carbonate or calcium phosphate), binders (e.g., gum arabic, corn starch or gelatin), swelling agents (e.g., alginic acid, corn starch or pregelinated starch), sweeteners (e.g., sucrose or saccharin), flavors (e.g., peppermint, Gaultheria adenothrix oil or cherry), lubricating and wetting agents (e.g., magnesium stearate, talc or carboxymethyl cellulose).
Having now generally described this invention, a further understanding can be obtained by reference to certain specific examples which are provided herein for purposes of illustration only and are not intended to be limited unless otherwise specified.
Unless otherwise indicated, the developing conditions for silica gel TLC procedures were under chloroform/methanol-9/1. Mass spectra (MS) were performed in the FD mode (m/z) and nuclear magnetic resonance spectra (NMR) were measured using tetramethylsilane as the internal standard and CDCl3 as the solvent.
A solution of 273 mg (1 mmol) of 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-hexylpiperidine, 165 mg (1 mmol) of 1-bromohexane, 745 mg (5 mmols) of sodium iodide and 414 mg (3 mmols) of potassium carbonate in 20 ml of methyl isobutyl ketone was stirred and refluxed at 120°C C. overnight on an oil bath. After the reaction, the mixture was washed by adding 20 ml of water thereto. Then the organic phase was separated and the solvent was distilled off under reduced pressure. After purifying by silica gel column chromatography (eluent: methanol/chloroform, 1/100-1/50), the product was converted into the hydrochloride with an equimolar hydrogen chloride/dioxane solution.
Amount yielded 180 mg
Yield 46%
TLC Rf=0.68
MS 357 (M+)
NMR 0.83 (3H, t), 1.2-1.4 (6H, m), 1.7-1.9 (2H, m), 2.31 (2H, dd), 2.53 (2H, d), 2.7-2.8 (2H, m), 3.14 (2H, dd), 3.38 (2H, dd), 3.38 (2H, d), 6.92 (2H, s), 7.2-7.4 (8H, m)
Hereafter procedures were carried out in manner similar to Example 1.
Amount yielded 300 mg
Yield 72%
TLC Rf=0.71
MS 385 (M+)
NMR 0.85 (3H, t), 1.2-1.4 (10H, m), 1.7-2.0 (2H, m), 2.30 (2H, dd), 2.53 (2H, d), 2.7-2.9 (2H, m), 3.13 (2H, dd), 3.38 (2H, d), 6.90 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 300 mg
Yield 67%
TLC Rf=0.75
MS 413 (M+)
NMR 0.85 (3H, t), 1.2-1.4 (14H, m), 1.7-1.9 (2H, m), 2.33 (2H, dd), 2.54 (2H, d), 2.7-2.8 (2H, m), 3.15 (2H, dd), 3.39 (2H, d), 6.92 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 1.10 g
Yield 92%
TLC Rf=0.78
MS 441 (M+)
NMR 0.85 (3H, t), 1.1-1.5 (18H, m), 1.7-1.9 (2H, m), 2.32 (2H, dd), 2.54 (2H, d), 2.7-2.8 (2H, m), 3.12 (2H, dd), 3.36 (2H, d), 6.93 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 1.20 g
Yield 95%
TLC Rf=0.78
MS 469 (M+)
NMR 0.82 (3H, t), 1.1-1.5 (22H, m), 1.7-1.9 (2H, m), 2.33 (2H, dd), 2.55 (2H, d), 2.7-2.8 (2H, m), 3.15 (2H, dd), 3.40 (2H, d), 6.92 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 1.18 g
Yield 88%
TLC Rf=0.80
MS 497 (M+)
NMR 0.80 (3H, t), 1.1-1.6 (26H, m), 1.7-1.9 (2H, m), 2.33 (2H, dd), 2.58 (2H, d), 2.7-2.8 (2H, m), 3.20 (2H, dd), 3.40 (.2H, d), 6.88 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 520 mg
Yield 51%
TLC Rf=0.75
MS 369 (M+)
NMR 0.8-2.1 (11H, m), 2.42 (2H, dd), 2.65 (2H, d), 2.78 (2H, d), 3.20 (2H, dd), 3.42 (2H, d), 6.91 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 780 mg
Yield 74%
TLC Rf=0.75
MS 383 (M+)
NMR 0.8-2.1 (13H, m), 2.45 (2H, dd), 2.67 (2H, d), 2.7-2.9 (2H, m), 3.0 (2H, dd), 3.48 (2H, d), 6.94 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 1.02 g
Yield 94%
TLC Rf=0.77
MS 397 (M+)
NMR 0.8-2.1 (15H, m), 2.47 (2H, dd), 2.68 (2H, d), 2.7-2.9 (2H, m), 3.0 (2H, dd), 3.49 (2H, d), 6.94 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 815 mg
Yield 72%
TLC Rf=0.78
MS 411 (M+)
NMR 0.8-2.1 (17H, m), 2.28 (2H, dd), 2.52 (2H, 2.7-2.9 (2H, m), 3.08 (2H, dd), 3.35 (2H, d), 6.92 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 750 mg
Yield 65%
TLC Rf=0.80
MS 411 (M+)
NMR 0.8-2.1 (19H, m), 2.25 (2H, dd), 2.68 (2H, d), 2.7-2.9 (2H, m), 3.12 (2H, dd), 3.38 (2H, d), 6.92 (2H, s), 7.1-7.4 (8H, m)
Amount yielded 320 mg
Yield 80%
TLC Rf=0.42
MS 363 (M+)
NMR 2.28 (2H, dd), 2.52 (2H, d), 3.14 (2H, dd), 3.31 (2H, d), 4.01 (2H, d), 6.90 (2H, s), 7.1-7.6 (13H, m)
Amount yielded 310 mg
Yield 75%
TLC Rf=0.45
MS 377 (M+)
NMR 2.28 (2H, dd), 2.51 (2H, d), 3.0-3.3 (6H, m), 3.47 (2H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 330 mg
Yield 77%
TLC Rf=0.50
MS 391 (M+)
NMR 2.1-2.4 (4H, m), 2.51 (2H, d), 2.65 (2H, t), 2.7-2.9 (2H, m), 3.12 (2H, dd), 3.38 (2H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 180 mg
Yield 41%
TLC Rf=0.50
MS 405 (M+)
NMR 1.4-1.9 (4H, m), 2.28 (2H, dd), 2.52 (2H, d), 2.61 (2H, t), 2.7-2.8 (2H, m), 3.12 (2H, .dd), 3.35 (2H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 110 mg
Yield 24%,
TLC Rf=0.55
MS 419 (M+)
NMR 1.2-1.9 (6H, m), 2.25 (2H, dd), 2.52 (2H, d), 2.60 (2H, t), 2.7-2.8 (2H, m), 3.08 (2H, dd), 3.35 (2H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 315 mg
Yield 67%
TLC Rf=0.56
MS 433 (M+)
NMR 1.1-1.9 (8H, m), 2.26 (2H, dd), 2.56 (2H, d), 2.61 (2H, t), 2.7-2.8 (2H, m), 3.10 (2H, dd), 3.35 (2H, d), 6.91 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 267 mg
Yield 55%
TLC Rf=0.56
MS 447 (M+)
NMR 1.1-1 (10H, m), 2.25 (2H, dd), 2.55 (2H, d), 2.65 (2H, t), 2.7-2.8 (2H, m), 3.07 (2H, dd), 3.32 (2H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
Amount yielded 1.95 g
Yield 55%
TLC Rf=0.56
MS 393 (M+)
NMR (fee base) 2.1-2.5 (2H, m), 2.58 (2H, t), 2.6-2.7 (2H, m), 4.05 (2H, t), 6.89 (2H, d), 6.92 (2H, s), 7.1-7.4 (11H, m)
Amount yielded 2.15 g
Yield 48%
TLC Rf=0.58
MS 407 (M+)
NMR (free base) 1.97 (2H, tt), 2.1-2.5 (6H, m), 2.54 (2H, t), 2.6-2.7 (2H, m), 3.97 (2H, dd), 6.86 (2H, d), 6.90 (2H, s), 7.1-7.4 (11H, m)
Amount yielded 1.18 g
Yield 86%
TLC Rf=0.61
MS 421 (M+)
NMR (free base) 1.8-2.7 (14H, m), 3.96 (2H, t), 6.87 (2H, d), 6.90 (2H, s), 7.1-7.4 (11H, m)
Amount yielded 0.97 g
Yield 87%
TLC Rf=0.55
MS 409 (M+)
NMR (free base) 2.0-2.6 (10H, m), 2.78 (2H, t), 6.86 (2H, s), 7.1-7.4 (11H, m)
Amount yielded 0.85 g
Yield 74%
TLC Rf=0.62
MS 423 (M+)
NMR (free base) 1.73 (2H, tt), 2.0-2.6 (10H, m), 2.80 (2H, t), 6.88 (2H, d), 7.1-7.4 (11H, m)
Amount yielded 0.85 g
Yield 72%
TLC Rf=0.62
MS 437 (M+)
NMR (free base) 1.6-2.6 (14H, m), 2.80 (2H, t), 6.88 (2H, d), 7.1-7.4 (11H, m)
TLC Rf=0.72
MS 502 (M+)
TLC Rf=0.51
MS 472 (M+)
TLC Rf=0.68
MS 544 (M+)
TLC Rf=0.85
MS 462 (M+)
TLC Rf=0.91
MS 498 (M+)
TLC Rf=0.78
MS 450 (M+)
TLC Rf=0.92
MS 532 (M+)
NMR 0.77 (3H, d), 1.18 (3H, d), 1.6-3.3 (15H, m), 3.86 (3H, s), 3.92 (3H, s), 6.8-7.4 (11H, m)
TLC Rf=0.78
MS 457 (M+)
TLC Rf=0.62
MS 473 (M+)
TLC Rf=0.84
MS 439 (M+)
TLC Rf=0.84
MS 420 (M+)
TLC Rf=0.55
MS 435 (M+)
1-(3-(2-Cinnamoylaminophenylthio)-1-propyl)-4-(5H-dibenzo[a,d]-cyclohepten-5-ylidene)piperidine hydrochloride
TLC Rf=0.66
MS 568 (M+)
NMR (free base) 1.74 (2H, tt), 2.0-2.6 (8H, m), 2.80 (2H, t), 6.59 (1H, d), 6.88 (2H, s), 7.0-7.6 (16H, m), 7.75 (1H, d), 8.5 (1H, d), 8.68 (1H, bs)
TLC Rf=0.84
MS 389 (M+)
NMR (free base) 2.1-2.7 (8H, m), 3.15 (2H, d), 6.25 (1H, td), 6.47 (1H, d), 6.90 (2H, s), 7.1-7.4 (13H, m)
TLC Rf=0.80
MS 563 (M+)
TLC Rf=0.48
MS 573 (M+)
TLC Rf=0.48
MS 573 (M+)
TLC Rf=0.94
MS 540 (M+)
TLC Rf=0.88
MS 548 (M+)
TLC Rf=0.74
MS 506 (M+)
TLC Rf=0.61
MS 479 (M+)
TLC Rf=0.86
MS 430 (M+)
TLC Rf=0.88
MS 472 (M+)
TLC Rf=0.81
MS 546 (M+)
TLC Rf=0.84
MS 444 (M+)
TLC Rf=0.84
MS 486 (M+)
TLC Rf=0.86
MS 560 (M+)
TLC Rf=0.92
MS 506 (M+)
TLC Rf=0.81
MS 538 (M+)
TLC Rf=0.91
MS 598 (M+)
TLC Rf=0.85
MS 580 (M+)
TLC Rf=0.90
MS 522 (M+)
TLC Rf=0.85
MS 480 (M+)
TLC Rf=0.87
MS 522 (M+)
TLC Rf=0.72
MS 498 (M+)
TLC Rf=0.75
MS 540 (M+)
TLC Rf=0.84
MS 472 (M+)
TLC Rf=0.88
MS 514 (M+)
TLC Rf=0.82
MS 574 (M+)
TLC Rf=0.90
MS 456 (M+)
TLC Rf=0.85
MS 516 (M+)
TLC Rf=0.61
MS 433 (M+)
TLC Rf=0.71
MS 475 (M+)
TLC Rf=0.55
MS 461 (M+)
TLC Rf=0.51
MS 550 (M+)
TLC Rf=0.88
MS 562 (M+)
TLC Rf=0.52
MS 564 (M+)
TLC Rf=0.91
MS 576 (M+)
TLC Rf=0.52
MS 578 (M+)
TLC Rf=0.90
MS 590 (M+)
TLC Rf=0.61
MS 592 (M+)
TLC Rf=0.91
MS 544 (M+)
TLC Rf=0.85
MS 504 (M+)
TLC Rf=0.92
MS 458 (M+)
TLC Rf=0.90
MS 518 (M+)
TLC Rf=0.93
MS 472 (M+)
TLC Rf=0.91
MS 532 (M+)
TLC Rf=0.95
MS 486 (M+)
TLC Rf=0.90
MS 546 (M+)
TLC Rf=0.95
MS 500 (M+)
TLC Rf=0.92
MS 560 (M+)
TLC Rf=0.95
MS 514 (M+)
TLC Rf=0.92
MS 574 (M+)
TLC Rf=0.95
MS 528 (M+)
TLC Rf=0.91
MS 588 (M+)
TLC Rf=0.94
MS 542 (M+)
TLC Rf=0.94
MS 602 (M+)
TLC Rf=0.95
MS 556 (M+)
TLC Rf=0.93
MS 616 (M+)
TLC Rf=0.95
MS 570 (M+)
TLC Rf=0.94
MS 630 (M+)
TLC Rf=0.71
MS 391 (M+)
TLC Rf=0.36
MS 393 (M+)
TLC Rf=0.74
MS 405 (M+)
TLC Rf=0.35
MS 407 (M+)
TLC Rf=0.75
MS 419 (M+)
TLC Rf=0.39
MS 421 (M+)
TLC Rf=0.76
MS 433 (M+)
TLC Rf=0.78
MS 447 (M+)
TLC Rf=0.80
MS 409 (M+)
TLC Rf=0.44
MS 411 (M+)
TLC Rf=0.80
MS 423 (M+)
TLC Rf=0.44
MS 425 (M+)
TLC Rf=0.45
MS 439 (M+)
TLC Rf=0.84
MS 451 (M+)
TLC Rf=0.51
MS 453 (M+)
TLC Rf=0.75
MS 381 (M+)
TLC Rf=0.79
MS 381 (M+)
TLC Rf=0.61
MS 381 (M+)
TLC Rf=0.83
MS 431 (M+)
TLC Rf=0.82
MS 431 (M+)
TLC Rf=0.79
MS 431 (M+)
TLC Rf=0.61
MS 393 (M+)
TLC Rf=0.61
MS 393 (M+)
TLC Rf=0.52
MS 393 (M+)
TLC Rf=0.80
MS 453 (M+)
TLC Rf=0.86
MS 440 (M+)
TLC Rf=0.82
MS 488 (M+)
TLC Rf=0.75
MS 500 (M+)
TLC Rf=0.68
MS 481 (M+)
TLC Rf=0.82
MS 437 (M+)
TLC Rf=0.66
MS 562 (M+)
MD | TLC | |||
exp | compound | (M+) | (Rf) | solvent |
127 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl-1-(4-fluorophenyl)ethane hydrochloride | 395 | 0.55 | B |
128 | 1-(2-Chlorobenzyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 397 | 0.68 | B |
129 | 1-(3-Chlorobenzyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 397 | 0.58 | B |
130 | 1-(4-Chlorobenzyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 397 | 0.58 | B |
131 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-methylbenyl)piperidine hydrochloride | 377 | 0.74 | B |
132 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-methylbenyl)piperidine hydrochloride | 377 | 0.71 | B |
133 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-methylbenyl)piperidine hydrochloride | 377 | 0.65 | B |
134 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-heptylpiperidine hydrochloride | 371 | 0.70 | B |
135 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-nondecylpiperidine hydrochloride | 399 | 0.75 | B |
136 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-undecylpiperidine hydrochloride | 427 | 0.75 | B |
137 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-tridecylpiperidine hydrochloride | 455 | 0.78 | B |
138 | 1-(2-Aminobenzy)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine dihydrochloride | 392 | 0.38 | B |
139 | 1-(3-Aminobenzy)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine dihydrochloride | 392 | 0.23 | B |
140 | 1-(4-Aminobenzy)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine dihydrochloride | 392 | 0.26 | B |
141 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-nitrobenzyl)piperidine hydrochloride | 422 | 0.85 | B |
142 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-nitrobenzyl)piperidine hydrochloride | 422 | 0.82 | B |
143 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-nitrobenzyl)piperidine hydrochloride | 422 | 0.83 | B |
144 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-(3-fluorophenyl)-2-isopropylvaleronitrile | 500 | 0.71 | B |
hydrochloride | ||||
145 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-isopropyl-2-(3-methoxyphenyl)valeronitrile | 512 | 0.64 | B |
hydrochloride | ||||
146 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-isopropyl-2-(3-methylphenyl)valeronitrile | 496 | 0.68 | B |
hydrochloride | ||||
147 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-isopropyl-2-(2- | 549 | 0.78 | B |
trifluoromethylphenyl)valeronitrile hydrochloride | ||||
148 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-isopropyl-2-(4- | 540 | 0.77 | B |
trifluoromethylphenyl)valeronitrile hydrochloride | ||||
149 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-ethyl-2-(3- | 526 | 0.77 | B |
trifluoromethylphenyl)valeronitrile hydrochloride | ||||
150 | 2-Butyl-5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-(3- | 554 | 0.80 | B |
trifluoromethylphenyl)valeronitrile hydrochloride | ||||
151 | 5-(4-(5H-Dibenzo[ac]cyclohepten-5-ylidene)-1-piperidinyl)-2-hexyl-2-(3- | 582 | 0.80 | B |
trifluoromethylphenyl)valeronitrile hydrochloride | ||||
152 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-phenyl-1-butene hydrochloride | 403 | 0.51 | B |
153 | 1-Benzyloxy-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethane hydrochloride | 407 | 0.58 | B |
154 | 1-Cyclohexyl-6-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)hexane hydrochloride | 439 | 0.62 | B |
155 | 1-Cyclohexyl-7-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)heptane hydrochloride | 453 | 0.65 | B |
156 | 1-Cyclohexyl-8-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)octane hydrochloride | 467 | 0.68 | B |
157 | 1-(4-Cyclohexylbutanoyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine | 425 | 0.75 | B |
158 | 1-(2-Cyanobenzyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 388 | 0.83 | B |
159 | 1-(3-Cyanobenzyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 388 | 0.85 | B |
160 | 1-(4-Cyanobenzyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 388 | 0.70 | B |
161 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-Picolyl)piperidine dihydrochloride | 364 | 0.58 | B |
162 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-Picolyl)piperidine dihydrochloride | 364 | 0.53 | B |
163 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-Picolyl)piperidine dihydrochloride | 364 | 0.44 | B |
164 | 1-Decanolyl-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine | 427 | 0.75 | B |
165 | 1-Cyano-3-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 340 | 0.58 | B |
166 | 1-Cyano-4-[4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 354 | 0.52 | B |
167 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethoxyacetophenone hydrochloride | 451 | 0.85 | B |
168 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethoxypropiophenone hydrochloride | 465 | 0.61 | B |
169 | 5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethoxyvalerophenone hydrochloride | 193 | 0.64 | B |
170 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4',5'-trimethoxybutyrophenone | 509 | 0.82 | B |
hydrochloride | ||||
171 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2',3',4'-trimethoxybutyrophenone | 509 | 0.86 | B |
hydrochloride | ||||
172 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-4'-trimethoxybutyrophenone | 449 | 0.61 | B |
hydrochloride | ||||
173 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2,3-dimethoxybenzyl)piperidine hydrochloride | 423 | 0.63 | B |
174 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4-dimethoxybenzyl)piperidine hydrochloride | 423 | 0.73 | B |
175 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4-dimethoxybenzyl)piperidine | 437 | 0.58 | B |
176 | 1-Cyclohexyl-3,(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propylketone hydrochloride | 425 | 0.51 | B |
177 | 2-Cyclohexyl-5,(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)valeronitrile hydrochloride | 436 | 0.60 | B |
178 | 1-(4-(3-Chloro-5H-dibenzo[a,d]cyclohepten-5-ylidene-1-piperidinyl)-4-cyclohexylbutane hydrochloride | 445 | 0.62 | B |
179 | 1-Cyclohexyl-(4-(3-methoxy-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane hydrochloride | 441 | 0.59 | B |
180 | 4,9-Dihydro-4-(1-(4-cyclohexylbutyl)-4-piperidinylidene-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one | 433 | 0.45 | B |
hydrochloride | ||||
181 | 1-(4-Cyclohexylbutyl-4-(9-xantylidene)piperidine hydrochloride | 401 | 0.64 | B |
182 | 1-(4-Cyclohexylbutyl-4-(9-thioxantylidene)piperidine hydrochloride | 417 | 0.65 | B |
183 | 6,11-Dihydro-11-(1-(4-cyclohexylbutyl)-4-piperidinylidene-5H-dibenzop[5,6]cycloheptal[1,2-b]pyridine | 414 | 0.41 | B |
dihydrochloride | ||||
184 | 4-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-methoxybenzyl)piperidine hydrochloride | 395 | 0.73 | B |
185 | 1-Decyl-4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 415 | 0.52 | B |
186 | 1-Cyclohexyl-4-(10,11-Dihydro-5H-dibenzo[a,d]cycloheptan-5-ylidene)-1-piperidinyl)butane | 413 | 0.67 | B |
hydrochloride | ||||
187 | 4-(4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethoxy- | 481 | 0.66 | B |
butyrophenone hydrochloride | ||||
188 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4,5-trimethoxybenzyl)piperidine | 453 | 0.69 | B |
189 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4,5-trimethoxybenzoyl)piperidine | 467 | 0.71 | B |
190 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-methylbenzoyl)piperidine | 391 | 0.73 | B |
191 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-(4-fluorophenyl)acetyl)piperidine | 409 | 0.76 | B |
192 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-dimethoxycinnamoyl)piperidine | 463 | 0.73 | B |
193 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-dimethoxycinnamyl)piperidine hydrochloride | 449 | 0.46 | B |
194 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-diethoxybutyrophenone hydrochloride | 501 | 0.49 | B |
195 | 1-(4-(4-Aminophenyl)butyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidine)piperidine dihydrochloride | 420 | 0.34 | B |
196 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-(4-nitrophenyl)butyl)piperidine hydrochloride | 450 | 0.50 | B |
197 | 1-(4-(4-Acetylaminophenyl)butyl-4-(5H-dibenzo[a,d]cyclohepten-5-ylidine)piperidine dihydrochloride | 462 | 0.48 | B |
198 | 4-(4-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethylbutyrophenone hydrochloride | 447 | 0.53 | B |
199 | Ethyl 4-(4-(5H-dibanzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyrate hydrochloride | 387 | 0.51 | B |
200 | 4-((4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyric acid | 359 | 0.15 | B |
201 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(-3-(3',4'-dimethoxyphenyl)propyl)piperidine hydrochloride | 451 | 0.60 | B |
202 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-(3',4'-dimethoxyphenyl)propanoyl)piperidine | 465 | 0.78 | B |
203 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)piperidine hydrochloride | 426 | 0.60 | B |
204 | N-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)-1,2,3,4-tetrahydroisoquinoline | 474 | 0.42 | B |
hydrochloride | ||||
205 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3,4-dimethoxy)phenyl-1-hydroxybutane | 481 | 0.38 | B |
hydrochloride | ||||
206 | 1-Acetoxy-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-(3,4-dimethoxy)phenylButane | 523 | 0.49 | B |
hydroxybutane hydrochloride | ||||
207 | 1-butyl-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3,4-dimethoxy)phenyl-1- | 537 | 0.45 | B |
hydroxybutane hydroxybutane hydrochloride | ||||
208 | 1-(4-Methoxyxyxlohexyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 441 | 0.55 | B |
hydroxybutane hydrochloride | ||||
209 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyl)piperidine | 412 | 0.03 | B |
dihydroxybutane hydrochloride | ||||
210 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-N-imidazolylmethyl)cinnamyl)piperidine | 469 | 0.44 | B |
dihydroxybutane hydrochloride | ||||
211 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-naphthoyl)piperidine | 427 | 0.88 | B |
212 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-naphthylmethyl)piperidine hydrochloride | 413 | 0.94 | B |
213 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(1-naphthoyl)piperidine | 427 | 0.59 | B |
214 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(1-naphthylmethyl)piperidine hydrochloride | 413 | 0.83 | B |
215 | 2-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyl)cyclohexanone hydrochloride | 426 | 0.50 | B |
(H+ | ||||
216 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)-4-hydroxypiperidine hydrochloride | 442 | 0.58 | B |
217 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)-4-ethoxyxarbonpiperidine | 499 | 0.26 | B |
hydrochloride | ||||
218 | Cyclohexyl 3-(4-(5H-Dibenzo[a,d]cyclohpetan-5-ylidene)-1-piperidinyl)propylether hydrochloride | 413 | 0.48 | B |
219 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-butyl)-1-methoxycarbonylcyclohexane | 470 | 0.55 | B |
hydrochloride | (H+) | |||
220 | Ethyl 2-cyclohexyl-5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)valerate hydrochloride | 483 | 0.65 | B |
221 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-(3',4'-dimethoxyphenyl)butyl)piperidine hydrochloride | 465 | 0.66 | B |
222 | 2-(3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propyl-2-(3,4-dimethoxyphenyl)- | 523 | 0.54 | B |
1,3-dioxolane hydrochloride | ||||
223 | 1-Carboxyl-1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butylcyclohexane hydrochloride | 456 | 0.38 | B |
(H+) | ||||
224 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(1,2,3,4-tetrahydro-2-naphthoyl)piperidine | 431 | 0.90 | B |
225 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(1,2,3,4-tetrahydro-2-naphthylmethyl)piperidine | 417 | 0.55 | B |
226 | N-(3,(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propanoyl)cyclohexylamine hydrochloride | 426 | 0.64 | B |
227 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl cyclohexanecarboxylate hydrochloride | 427 | 0.71 | B |
228 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-cyclohexylbutane hydrochloride | 431 | 0.74 | B |
229 | 4-(4-(5H-Dibenzo[a,d]thiepin-5-ylidene)-1-piperidinyl)-3+,4+-dimethoxybutyrophenone hydrochloride | 499 | 0.46 | B |
230 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-nitrocinnamyl)piperidine hydrochloride | 434 | 0.70 | B |
231 | 1-(4-Aminocinnamyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 404 | 0.36 | B |
232 | 1-(4-Acetylaminocinnamyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)piperidine dihydrochloride | 446 | 0.27 | B |
233 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-furyl)-1-butanone hydrochloride | 409 | B | |
234 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-thienyl)-1-butanone hydrochloride | 425 | B | |
235 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propyl(2-tetrahydropyranyl)ether | 415 | 0.55 | B |
hydrochloride | ||||
236 | Cyclohexyl 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propionate hydrochloride | 427 | 0.71 | B |
237 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl-4-nitrobenzamide hydrochloride | 465 | 0.49 | H |
238 | 2-Cyclohexyl-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyric acid | 455 | 0.26 | B |
239 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propyl phenylsulphoxide hydrochloride | 409 | 0.29 | H |
240 | 2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl-5',6'-dimethoxyindan hydrochloride | 477 | 0.41 | B |
241 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propyl phenylsulphone hydrochloride | 441 | 0.36 | B |
242 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl-3',4'-dimethoxybenzamide hydrochloride | 480 | 0.44 | G |
243 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl cyclohexanecarboxamide hydrochloride | 426 | 0.75 | B |
244 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl isonicotinamide hydrochloride | 421 | 0.20 | B |
245 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)morpholine hydrochloride | 428 | 0.31 | C |
246 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butanoyl)thiomorpholine hydrochloride | 444 | 0.43 | C |
247 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(4-notrophenyl)propane hydrochloride | 436 | 0.34 | H |
248 | 1-(4-Aminophenyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane dihydrochloride | 406 | 0.13 | B |
249 | 1-(4-Acetylaminophenyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane | 448 | 0.43 | B |
dihydrochloride | ||||
250 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-nitrophenyl)propane hydrochloride | 436 | 0.53 | H |
251 | 1-(2-Aminophenyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane dihydrochloride | 406 | 0.52 | B |
252 | 1-(2-Acetylaminophenyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane | 448 | 0.51 | B |
dihydrochloride | ||||
253 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethylphenylsulphoxide hydrochloride | 425 | 0.20 | H |
254 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl phenylsulphone hydrochloride | 455 | 0.71 | B |
255 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-nitrophenyl)butane hydrochloride | 450 | 0.49 | H |
256 | Cyclohexyl-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propylsulphide hydrochloride | 430 | 0.17 | J |
(H+) | ||||
257 | Cyclohexyl-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propylsulphoxide hydrochloride | 445 | 0.51 | B |
258 | Cyclohexyl-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propylsulphone hydrochloride | 462 | 0.28 | H |
(H+) | ||||
259 | Ethyl 2-cyclohexylmethyl-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyrate | 483 | 0.70 | B |
hydrochloride | ||||
260 | 1-(4-acetylamino-1-cyclohexyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 468 | 0.43 | B |
hydrochloride | ||||
261 | 2-(2-4-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)-5',6'-dimethoxy-1-indanone | 477 | 0.41 | B |
hydrochloride | ||||
262 | Ethyl 2-(2-cyclohexylethyl-3-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propionate | 483 | 0.74 | B |
hydrochloride | ||||
263 | Cyclohexylmethyl-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylsulfone hydrochloride | 461 | 0.94 | B |
264 | Cyclohexylmethyl-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethylsulfoxide | 441 | 0.48 | B |
hydrochloride | (H+) | |||
265 | Cyclohexylmethyl-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethylsulfide hydrochloride | 429 | 0.85 | B |
266 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-4-amino-6,7-dimethoxyquinazoline | 476 | 0.34 | B |
dihydrochloride | ||||
267 | N-Acetyl-N-(3-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propylcyclohexylamine | 454 | 0.35 | B |
hydrochloride | ||||
268 | N-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-2-piperidone hydrochloride | 426 | 0.39 | B |
269 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-1-ethoxycarbonxylcyclohexane | 483 | 0.82 | B |
hydrochloride | ||||
270 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3-pyridyl)propane dihydrochloride | 392 | 0.44 | B |
271 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'-dimethoxybutyrophenone N-oxide | 477 | 0.45 | B |
(M-18) | ||||
272 | 1-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-1-hydroxymethylcyclohexane | 441 | 0.55 | B |
hydrochloride | ||||
273 | 1-Acetoxymethyl-1-(4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)cyclohexane | 483 | 0.86 | B |
hydrochloride | ||||
274 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-methyl-3',4'-dimethoxybutyrophenone | 493 | 0.22 | B |
hydrochloride | ||||
275 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-(2-propyl)-3',4'-dimethoxybutyrophenone | 521 | 0.28 | H |
hydrochloride | ||||
276 | 2-Allyl-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-3',4'dimethoxybutyrophenone | 519 | 0.30 | H |
hydrochloride | ||||
277 | 4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-(1-propyl)-3',4'-dimethoxybutyrophenone | 521 | 0.38 | H |
hydrochloride | ||||
278 | 4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-ethyl-3',4'-dimethoxybutyrophenone | 507 | 0.33 | H |
hydrochloride | ||||
279 | Cyclohexylmethyl-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-2-ethyl)ether hydrochloride | 413 | 0.73 | B |
280 | 1-(n-Acetyl-3-piperidinyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 440 | 0.75 | B |
281 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3-piperidinyl)propane dihydrochloride | 398 | 0.16 | A |
282 | 1-(3-Acetylamino-4-methoxyphenyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 492 | 0.58 | B |
hydrochloride | ||||
283 | 4-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)cyclohexane hydrochloride | 425 | 0.63 | B |
284 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-pyridyl)-1-propane hydrochloride | 390 | 0.66 | H |
285 | 2,6-Dimethyl-4-(4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butyl)-5-methyl-1,4- | 528 | 0.30 | F |
dihydropyrydine-3,5-dicarboxylate hydrochloride | ||||
286 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2,3-dimethoxyphenyl)propane hydrochloride | 451 | 0.68 | H |
287 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methyl-5',6'-dimethoxyindan hydrochloride | 463 | 0.59 | H |
288 | 2,6-Dimethyl-4-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-5-methylpyrydine- | 527 | 0.68 | B |
3,5-dicarboxylate dihydrochloride | ||||
289 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(4-pyridyl)propane dihydrochloride | 392 | 0.37 | B |
290 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl-3-nitrobenzamide hydrochloride | 466 | 0.48 | D |
(H+) | ||||
291 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl-2-nitrobenzamide hydrochloride | 466 | D | |
(H+) | ||||
292 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethyl-2,4-dimethoxybenzamide hydrochloride | 481 | 0.31 | D |
(H+) | ||||
293 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-pyrolle)-1-butane hydrochloride | 409 | B | |
(H+) | ||||
294 | 1-(N-Acetyl-2-piperidinyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 440 | 0.30 | B |
295 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(N-methyl-3-piperidinyl)butane dihydrochloride | 426 | 0.07 | B |
296 | 1-(1-(4-Hydroxy)cyclohexyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane hydrochloride | 427 | 0.45 | B |
297 | 1-(1-(4-Cyano)cyclohexyl)-4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane hydrochloride | 436 | 0.55 | F |
298 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-methoxyphenyl)propane hydrochloride | 421 | 0.81 | B |
299 | 1-(1-(3-Methoxy)cyclohexyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 441 | 0.71 | B |
hydrochloride | ||||
300 | 1-(1-(3-Hydroxyoxy)cyclohexyl)-4-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 427 | 0.47 | B |
hydrochloride | ||||
301 | 3-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)cyclohexanoe hydrochloride | 425 | 0.70 | B |
302 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-nitrocinnamyl)piperidinyl hydrochloride | 434 | 0.91 | B |
303 | 1-(2-Aminocinnamyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine hydrochloride | 404 | 0.62 | B |
304 | 1-(2-Acetylaminocinnamyl)-4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine hydrochloride | 446 | 0.55 | B |
305 | 4-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)tetrahydropyran hydrochloride | 413 | 0.69 | B |
306 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-nitrocinnamyl)piperidine hydrochloride | 984 | 0.90 | B |
307 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2-piperidinyl)propane dihydrochloride | 398 | 0.07 | A |
308 | 1-(N-acetyl-4-piperidinyl)-3-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 440 | 0.23 | H |
309 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane dihydrochloride | 398 | 0.03 | B |
310 | 2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)indane hydrochloride | 417 | 0.59 | B |
311 | 4-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ehtyl)-2,4,5,6-tetramethyl- | 524 | 0.68 | B |
1,4-dihydropyridino-3,5-dicarboxylate hydrochloride | ||||
312 | 4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(N-ethoxycarbonyl-3-piperidinyl)butane | 484 | 0.64 | B |
hydrochloride | ||||
313 | 1-(5-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-pentyl)-1-methoxycarbonylcyclohexane | 483 | 0.72 | B |
hydrochloride | ||||
314 | 1-(3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-propyl)-1-methoxycarbonylcyclohexane | 455 | 0.75 | B |
hydrochloride | ||||
315 | 1-(3-Aminophenyl)-3-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane dihydrochloride | 993 | 0.62 | B |
316 | 1-(3-Acetylaminophenyl)-3-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane hydrochloride | 994 | 0.48 | B |
317 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3,4,5-trimethoxyphenyl)propane | 481 | 0.65 | B |
dihydrochloride | ||||
318 | 2-(3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)-5,6-dimethoxy- | 491 | 0.21 | H |
1,2,34-tetrahydronaphthalene hydrochloride | ||||
319 | 6-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methyl-2,3-dimethoxybenzocycloheptene | 491 | 0.56 | H |
hydrochloride | ||||
320 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4,5-trimethoxycinnamyl)piperdine hydrochloride | 479 | 0.69 | B |
321 | 1-(N-Acetyl-4-piperidinyl)-5-(4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-pentene | 466 | 0.33 | B |
dihydrochloride | ||||
322 | 2-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-3,4,5,6-tetrmethyl- | 1000 | 0.30 | B |
1,4-dihydropyridine-3,5-dicarboxylate hydrochloride | ||||
323 | 2-(4-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-butyl)-3,4-5,6-tetramethylpyridine- | 550 | 0.43 | B |
3,5-dicarboxylate hydrochloride | ||||
324 | 1-(1-(4-Methoxy)cyclohecyl)-3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)propane | 427 | 0.48 | B |
hydrochloride | ||||
325 | (5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-nitrocinnamyl)piperidine hydrochloride | 454 | 0.89 | B |
326 | 1-(4-Aminocinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine dihydrochloride | 424 | 0.65 | B |
327 | 1-(4-Acetylaminominocinnamyl)-4-(5H-Dibenzo[a,d]thiepiz-5-ylidene)-1-piperidine hydrochloride | 466 | 0.58 | B |
328 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(2,4-dimethoxyphenyl)propane dihydrochloride | 451 | 0.64 | B |
329 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methyl-4'-nitroindan hydrochloride | 448 | 0.49 | I |
330 | 4'-Amino-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methylindan hydrochloride | 418 | 0.38 | H |
331 | 4'Acetylamino-2(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-Piperidinyl)methylindan hydrochloride | 460 | 0.33 | B |
332 | 2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methyl-5'-nitroindan hydrochloride | 448 | 0.51 | I |
333 | 5'-Amino2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methylindan hydrochloride | 418 | 0.34 | B |
334 | 5'-acetylamino-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)methylindan hydrochloride | 460 | 0.29 | H |
335 | 4-Amino-N-(2-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylbenzamide hydrochloride | 435 | B | |
336 | 3-Amino-N-(2-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylbenzamide hydrochloride | 435 | B | |
337 | 1-Formyl-N-(2-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylisonipecotinamide hydrochloride | 455 | B | |
338 | 1-Formyl-N-(2-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylisonicotinamide hydrochloride | 455 | B | |
339 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylnicotinamide hydrochloride | 421 | 0.42 | B |
340 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethnicotinamide N-oxide hydrochloride | 437 | 0.27 | D |
(H+) | ||||
341 | N-(2-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)ethylisonicotinamide N-oxide hydrochloride | 437 | 0.30 | D |
(H+) | ||||
342 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2,4-dimethoxycinnamyl)piperidine hydrochloride | 449 | 0.73 | B |
343 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2,5-dimethoxycinnamyl)piperidine hydrochloride | 449 | 0.73 | B |
344 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2,3-dimethoxycinnamyl)piperidine hydrochloride | 449 | 0.90 | B |
345 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,5-dimethoxycinnamyl)piperidine hydrochloride | 449 | 0.74 | B |
346 | 1-(4-Cyanocinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine hydrochloride | 414 | 0.70 | B |
347 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-methoxycinnamyl)piperidine hydrochloride | 419 | 0.87 | B |
348 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-methoxycinnamyl)piperidine hydrochloride | 419 | 0.89 | B |
349 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine hydrochloride | 419 | 0.85 | B |
350 | 4-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-nitrocinnamyl)piperidine hydrochloride | 436 | 0.93 | B |
351 | 1-(4-Aminocinnamyl)-4-(10,11-dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine dihydrochloride | 406 | 0.64 | B |
352 | 1-(4-Acetylaminocinnamyl)-4-(10,11 dihydro-5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine | 448 | 0.54 | B |
dihydrochloride | ||||
353 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-4-fluorocinnamyl)piperidine hydrochloride | 407 | 0.88 | B |
354 | 2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)-4'-nitroindan hydrochloride | 462 | 0.34 | H |
355 | 4'-Amino-2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)indan hydrochloride | 432 | 0.53 | B |
356 | 4'-Caetylamino-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)indan hydrochloride | 474 | 0.24 | B |
357 | 2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)-5'-nitroindan hydrochloride | 462 | 0.31 | H |
358 | 5'-Amino-2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)indan dihydrochloride | 432 | 0.23 | H |
359 | 5'-Acetylamino-2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)indan dihydrochloride | 474 | 0.05 | H |
360 | 2-(2-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-ethyl)-5'-methanesulfonylaminoindan | 510 | 0.11 | H |
hydrochloride | ||||
361 | 1-(Cyclohexyl-4-(4-(10,11-dihydroxy-5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)butane | 445 | 0.84 | B |
362 | 3-(4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidinyl)-1-(3-pyridyl)-1-propene dihydrochloride | 390 | 0.44 | B |
363 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-hydroxycinnamyl)piperidine hydrochloride | 406 | 0.55 | B |
(H+) | ||||
364 | 1-(4-Acetoxycinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 447 | 0.87 | B |
365 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-hydroxy-3-methoxycinnamyl)piperidine hydrochloridine | 435 | 0.63 | B |
366 | 1-(4-Acetoxy-3-methoxycinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-piperidine hydrochloride | 477 | 0.83 | B |
367 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-hydroxycinnamyl)piperidine hydrochloride | 405 | 0.45 | B |
368 | 1-(3-Acetoxycinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 447 | 0.80 | B |
369 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-(2-methoxyacetoxy)cinnamyl)piperidine hydrochloride | 477 | 0.65 | B |
370 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-propanoylaminocinnamyl)piperidine hydrochloride | 460 | 0.21 | H |
371 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-ethoxycarbonylaminocinnamyl)piperidine hydrochloride | 476 | 0.20 | H |
372 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-methanesulfonylaminocinnamyl)piperidine hydrochloride | 482 | 0.44 | B |
373 | 1-(N,N-Bis(methanesulfonyl)amminocinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine | 560 | 0.88 | B |
hydrochloride | ||||
374 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-methoxycarbonylcinnamyl)piperidine hydrochloride | 447 | 0.55 | B |
375 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-methoxycarbonylcinnamyl)piperidine hydrochloride | 447 | 0.48 | H |
376 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-methoxycarbonylcinnamyl)piperidine hydrochloride | 447 | 0.50 | B |
377 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-3-methoxy-2-nitrocinnamyl)piperidine hydrochloride | 464 | 0.30 | H |
378 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-methoxycarbonylaminocinnamyl)piperidine hydrochloride | 462 | 0.53 | B |
379 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-pivaloy)aminocinnamyl)piperidine hydrochloride | 488 | 0.51 | B |
380 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-trifluoroacetylaminocinnamyl)piperidine hydrochloride | 500 | 0.44 | B |
381 | 1-(4-Butanoylaminocinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 474 | 0.50 | B |
382 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-ethoxycarbonylcinnamyl)piperidine hydrochloride | 477 | 0.85 | B |
383 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(4-(2-methoxyacetoxy)cinnamyl)piperidine hydrochloride | 477 | 0.45 | B |
384 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3,4-dihydroxycinnamyl)piperidine hydrochloride | 422 | 0.35 | B |
(H+) | ||||
385 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(2-indolylmethyl)piperidine hydrochloride | 402 | 0.67 | H |
386 | 1-(4-Aminosulfonylcinnamyl)-4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)piperidine hydrochloride | 468 | 0.48 | B |
(H+) | ||||
387 | 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-(3-methoxy-4-nitrocinnamyl)piperidine hydrochloride | 464 | 0.29 | H |
As test animals, four male spontaneously hypertensive rats (weight 400 to 440 g) that were sufficiently adapted for feeding and in which hypertension was confirmed were used.
Physiological saline aqueous solution containing 2.5% Nicolle and 2.5% ethanol of sample was intravenously administered by bolus injection at a dose of 1 ml per 1 kg of body weight. Systolic blood pressure after administration was measured by the indirect (tail-cuff) method.
The results are shown below.
Decrease in systolic blood pressure | |||
Dose | (mmHg) time after administration (hour) | ||
Compound | (mg/kg) | 0.5 | 4 |
1 | 10 | -67 | 1 |
2 | 10 | -125 | -34 |
3 | 3 | -110 | -22 |
4 | 10 | -76 | 0 |
5 | 10 | -56 | -20 |
7 | 10 | -57 | -15 |
8 | 10 | -95 | -21 |
9 | 10 | -91 | -19 |
10 | 10 | -129 | -21 |
11 | 10 | -166 | |
12 | 10 | -27 | 1 |
13 | 10 | -47 | 4 |
14 | 10 | -105 | -10 |
15 | 10 | -130 | -136 |
16 | 10 | -114 | -30 |
17 | 10 | -84 | -16 |
20 | 10 | -37 | 2 |
23 | 10 | -34 | 10 |
25 | 10 | -8 | -7 |
28 | 10 | -52 | 4 |
31 | 10 | -61 | -11 |
37 | 10 | -78 | -36 |
38 | 10 | -140 | -76 |
42 | 10 | -66 | -14 |
45 | 10 | -147 | -38 |
52 | 10 | -23 | -9 |
59 | 10 | -87 | -21 |
60 | 10 | -121 | -48 |
100 | 10 | -35 | -5 |
101 | 10 | -89 | -14 |
107 | 10 | -88 | -11 |
108 | 10 | -126 | -50 |
111 | 10 | -98 | -13 |
112 | 10 | -16 | 0 |
113 | 1 | -151 | -81 |
115 | 10 | -53 | -19 |
116 | 10 | -36 | -12 |
117 | 10 | -143 | -25 |
118 | 10 | -129 | -24 |
119 | 10 | -34 | -5 |
120 | 3 | -17 | -12 |
121 | 10 | -42 | -19 |
122 | 10 | -120 | -62 |
123 | 10 | -55 | -7 |
124 | 10 | -90 | -20 |
125 | 10 | -93 | -14 |
126 | 10 | -87 | -19 |
128 | 10 | -129 | -8 |
129 | 10 | -17 | -1 |
130 | 10 | -42 | 9 |
131 | 10 | -116 | 2 |
132 | 10 | -106 | -5 |
133 | 3 | -146 | -84 |
134 | 10 | -115 | -30 |
135 | 10 | -132 | -50 |
136 | 10 | -100 | -40 |
138 | 10 | -129 | -33 |
139 | 10 | -139 | -89 |
140 | 3 | -113 | -101 |
142 | 10 | -43 | 0 |
149 | 10 | -116 | -32 |
150 | 10 | -110 | -47 |
151 | 10 | -81 | -43 |
154 | 10 | -131 | -105 |
155 | 10 | -131 | -105 |
156 | 10 | -110 | -42 |
157 | 10 | -32 | -13 |
158 | 10 | -8 | 7 |
159 | 10 | -27 | -12 |
160 | 10 | -3 | -10 |
161 | 10 | -64 | -12 |
162 | 10 | -62 | -3 |
163 | 10 | -1 | 4 |
164 | 10 | -91 | -22 |
165 | 10 | -22 | 12 |
166 | 10 | -45 | 6 |
168 | 10 | -108 | 0 |
169 | 10 | -130 | -4 |
171 | 10 | -122 | -8 |
172 | 10 | -115 | -25 |
173 | 10 | -98 | -25 |
174 | 10 | -8 | -16 |
175 | 10 | -87 | -1 |
176 | 10 | -105 | -10 |
180 | 10 | -25 | -24 |
181 | 10 | -56 | -27 |
182 | 10 | -11 | -6 |
184 | 10 | -16 | -4 |
185 | 10 | -66 | -10 |
186 | 10 | -95 | -12 |
187 | 10 | -47 | -9 |
188 | 10 | -94 | -12 |
189 | 10 | -72 | -15 |
190 | 10 | -11 | -15 |
191 | 10 | -29 | -20 |
192 | 10 | -25 | -36 |
193 | 10 | -124 | -59 |
194 | 10 | -59 | -17 |
195 | 10 | -100 | -51 |
196 | 10 | -145 | -81 |
197 | 10 | -51 | -26 |
198 | 10 | -124 | -25 |
199 | 10 | -15 | -24 |
200 | 10 | -10 | -24 |
201 | 10 | -118 | -21 |
202 | 10 | -54 | -16 |
203 | 3 | -123 | -58 |
204 | 10 | -141 | -84 |
205 | 10 | -22 | -4 |
206 | 10 | -61 | -27 |
207 | 10 | -98 | -43 |
208 | 10 | -131 | -19 |
209 | 10 | -49 | -13 |
210 | 1 | -78 | -69 |
212 | 10 | -155 | |
213 | 10 | -82 | 3 |
214 | 10 | -126 | -21 |
215 | 10 | -128 | -14 |
216 | 3 | -2 | -27 |
217 | 10 | -18 | -20 |
218 | 10 | -97 | -11 |
219 | 10 | -104 | -33 |
220 | 10 | -148 | -54 |
221 | 10 | -70 | -13 |
222 | 10 | -94 | -5 |
224 | 10 | -69 | -61 |
225 | 10 | -115 | -31 |
226 | 10 | -131 | -16 |
228 | 3 | -112 | -14 |
229 | 3 | -77 | -14 |
230 | 3 | -131 | -91 |
231 | 3 | -132 | -115 |
232 | 1 | -92 | -85 |
233 | 10 | -35 | -1 |
234 | 10 | -96 | -2 |
235 | 10 | -99 | -5 |
236 | 10 | -10 | -15 |
237 | 10 | -65 | -14 |
238 | 10 | -14 | -5 |
239 | 10 | -68 | -15 |
240 | 3 | -118 | -5 |
241 | 10 | -73 | -4 |
242 | 10 | -28 | 7 |
243 | 10 | -111 | -31 |
244 | 10 | -19 | 4 |
245 | 10 | -34 | -10 |
246 | 10 | -34 | -4 |
247 | 10 | -119 | -40 |
248 | 10 | -101 | -92 |
249 | 10 | -121 | -100 |
250 | 10 | -136 | -30 |
251 | 10 | -110 | -24 |
252 | 10 | -23 | -5 |
253 | 10 | -12 | 1 |
255 | 10 | -62 | 2 |
256 | 10 | -60 | -11 |
257 | 10 | -70 | -13 |
258 | 10 | -74 | -10 |
259 | 10 | -46 | -5 |
260 | 10 | -51 | -10 |
261 | 10 | -123 | -11 |
262 | 10 | -16 | -3 |
264 | 10 | -38 | -5 |
265 | 10 | -61 | -11 |
266 | 10 | -133 | -77 |
267 | 10 | -40 | 0 |
268 | 10 | -29 | 13 |
269 | 10 | 143 | -71 |
270 | 10 | -18 | 2 |
271 | 10 | -17 | -13 |
272 | 10 | -76 | -3 |
273 | 10 | -37 | 5 |
274 | 10 | -102 | -21 |
275 | 10 | -66 | -20 |
276 | 10 | -24 | -1 |
277 | 10 | -27 | 0 |
278 | 10 | -64 | 2 |
279 | 3 | -83 | -24 |
280 | 10 | -50 | -11 |
281 | 10 | -31 | -5 |
282 | 10 | -72 | -15 |
283 | 10 | -112 | 4 |
284 | 3 | -151 | -40 |
285 | 10 | -62 | -7 |
286 | 10 | -134 | -40 |
287 | 10 | -83 | -16 |
288 | 10 | -92 | -14 |
289 | 3 | -20 | 10 |
290 | 3 | -15 | 15 |
291 | 3 | -8 | 15 |
292 | 3 | -31 | 3 |
293 | 10 | -122 | 4 |
294 | 3 | -17 | 7 |
295 | 3 | -36 | 1 |
296 | 10 | -109 | -14 |
297 | 10 | -129 | -57 |
298 | 10 | -111 | -31 |
299 | 10 | -134 | -45 |
300 | 10 | -97 | -22 |
301 | 10 | -100 | -12 |
302 | 10 | -83 | -41 |
303 | 3 | -90 | -19 |
304 | 10 | -49 | -5 |
305 | 10 | -95 | -9 |
306 | 10 | -138 | -37 |
307 | 10 | -62 | -20 |
308 | 3 | -27 | -5 |
310 | 10 | -90 | -18 |
311 | 10 | -90 | -18 |
312 | 10 | -115 | -11 |
313 | 10 | -154 | -85 |
314 | 10 | -61 | -11 |
315 | 10 | -43 | -3 |
316 | 1 | -100 | 8 |
317 | 10 | -118 | -14 |
318 | 10 | -83 | -57 |
319 | 10 | -104 | -20 |
320 | 10 | -147 | -113 |
321 | 10 | -60 | -4 |
322 | 10 | -100 | -16 |
323 | 10 | -117 | -11 |
324 | 10 | -137 | -46 |
325 | 10 | -115 | -100 |
326 | 1 | -125 | -102 |
327 | 3 | -10 | -43 |
328 | 10 | -125 | -87 |
329 | 10 | -34 | -7 |
330 | 10 | -93 | -25 |
331 | 10 | -62 | -14 |
332 | 10 | -111 | -57 |
343 | 3 | -83 | -45 |
344 | 1 | -123 | -35 |
345 | 3 | -120 | -95 |
346 | 3 | -142 | -121 |
347 | 3 | -116 | -53 |
348 | 3 | -105 | -12 |
349 | 1 | -48 | -43 |
350 | 10 | -136 | -85 |
351 | 3 | -70 | -21 |
352 | 3 | -93 | -60 |
353 | 10 | -147 | -138 |
354 | 3 | -89 | -8 |
363 | 3 | -120 | |
364 | 1 | -113 | |
365 | 3 | -80 | -56 |
366 | 3 | -152 | -113 |
367 | 10 | -98 | -63 |
368 | 3 | -110 | -68 |
369 | 10 | -101 | -83 |
370 | 10 | -99 | -69 |
374 | 3 | -119 | 11 |
375 | 1 | -126 | -70 |
376 | 3 | -106 | -77 |
377 | 1 | -151 | -73 |
378 | 1 | -106 | -90 |
379 | 1 | -118 | -59 |
380 | 0.3 | -141 | |
381 | 3 | -136 | |
382 | 3 | -129 | -74 |
383 | 3 | -112 | -86 |
334 | 3 | -130 | -93 |
385 | 10 | -123 | -96 |
386 | 10 | -83 | -96 |
387 | 10 | -112 | -50 |
From the foregoing results, it is understood that the piperidine derivatives of the present invention possess hypotensive activity and are usable as hypotensives and therefore, they can be expected to provide an excellent hypotensive effect. Accordingly, the present invention is extremely useful, particularly in the pharmaceutical industry.
Having now fully described the invention, it will be apparent to one of ordinary skill in the art that many changes and modifications can be made thereto without departing from the spirit or scope of the invention as set forth herein.
Yoshimoto, Ryota, Kamimura, Akira, Shoji, Masataka, Toyota, Kozo, Eguchi, Chikahiko, Domoto, Hideki, Koyama, Yoshikatsu
Patent | Priority | Assignee | Title |
7317026, | Oct 16 2001 | HYPNION, INC | CNS target modulators |
7355042, | Oct 16 2001 | HYPNION, INC | Treatment of CNS disorders using CNS target modulators |
7411069, | Dec 10 2003 | HYPNION, INC | Doxepin analogs and methods of use thereof |
7482460, | Dec 10 2003 | HYPNION, INC | Doxepin analogs and methods of use thereof |
7524864, | Apr 23 2004 | HYPNION, INC | Methods of treating sleep disorders |
Patent | Priority | Assignee | Title |
4031222, | Dec 22 1975 | Merck & Co., Inc. | Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs |
4073912, | Oct 12 1976 | SmithKline Beckman Corporation | Piperidylidene derivatives of benzo-fused xanthenes, thioxanthenes and dibenzoxepins and antipsychotic use thereof |
4356184, | Jun 04 1980 | G D SEARLE AND CO , 1751 LAKE COOK RD , DEERFIELD, IL 60015 A CORP OF DE | Anti-allergic or antihypertensive 1-piperidinylmethyl benzenamines |
4912222, | Jun 17 1988 | Fisons Corporation | Antihistamines related to cyproheptadine |
5229400, | Oct 05 1990 | AJINOMOTO CO , INC | Piperidine compounds and their use as antiarrhythmic agents |
5231105, | Jun 02 1987 | AJINOMOTO CO , INC | Ethylamine derivatives and antihypertensives containing the same |
EP5607, | |||
GB1153977, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Feb 10 1999 | Ajinomoto Co., Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Aug 04 2006 | M1553: Payment of Maintenance Fee, 12th Year, Large Entity. |
Date | Maintenance Schedule |
Sep 23 2006 | 4 years fee payment window open |
Mar 23 2007 | 6 months grace period start (w surcharge) |
Sep 23 2007 | patent expiry (for year 4) |
Sep 23 2009 | 2 years to revive unintentionally abandoned end. (for year 4) |
Sep 23 2010 | 8 years fee payment window open |
Mar 23 2011 | 6 months grace period start (w surcharge) |
Sep 23 2011 | patent expiry (for year 8) |
Sep 23 2013 | 2 years to revive unintentionally abandoned end. (for year 8) |
Sep 23 2014 | 12 years fee payment window open |
Mar 23 2015 | 6 months grace period start (w surcharge) |
Sep 23 2015 | patent expiry (for year 12) |
Sep 23 2017 | 2 years to revive unintentionally abandoned end. (for year 12) |